nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Lingering Uncertainties and Emerging Possibilities
|
Mukherjee, Sudipto |
|
2015 |
21 |
3 |
p. 412-420 9 p. |
artikel |
2 |
A Reduced-Toxicity Regimen Is Associated with Durable Engraftment and Clinical Cure of Nonmalignant Genetic Diseases among Children Undergoing Blood and Marrow Transplantation with an HLA-Matched Related Donor
|
Mahadeo, Kris Michael |
|
2015 |
21 |
3 |
p. 440-444 5 p. |
artikel |
3 |
ASBMT News
|
|
|
2015 |
21 |
3 |
p. 576-577 2 p. |
artikel |
4 |
Biopsy-Verified Bronchiolitis Obliterans and Other Noninfectious Lung Pathologies after Allogeneic Hematopoietic Stem Cell Transplantation
|
Uhlving, Hilde Hylland |
|
2015 |
21 |
3 |
p. 531-538 8 p. |
artikel |
5 |
Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM)–Campath Allogeneic Stem Cell Transplantation for Aggressive Non-Hodgkin Lymphoma: An Analysis of Outcomes from the British Society of Blood and Marrow Transplantation
|
Truelove, Edward |
|
2015 |
21 |
3 |
p. 483-488 6 p. |
artikel |
6 |
CD161+ T Cells as Predictive Markers for Acute Graft-versus-Host Disease
|
Lee, Sung-Eun |
|
2015 |
21 |
3 |
p. 421-428 8 p. |
artikel |
7 |
Central Nervous System Involvement in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation
|
Bar, Merav |
|
2015 |
21 |
3 |
p. 546-551 6 p. |
artikel |
8 |
Company Reply to “Unexpected Outbreak of Epstein-Barr Virus Post-Transplantation Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation Conditioning with Thymoglobulin”
|
Janssen, Suzanne |
|
2015 |
21 |
3 |
p. 575- 1 p. |
artikel |
9 |
Comparison of Cord Blood Transplantation with Unrelated Bone Marrow Transplantation in Patients Older than Fifty Years
|
Tanaka, Masatsugu |
|
2015 |
21 |
3 |
p. 517-525 9 p. |
artikel |
10 |
Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation
|
Copelan, Edward A. |
|
2015 |
21 |
3 |
p. 552-558 7 p. |
artikel |
11 |
Comparison of Unrelated Cord Blood and Peripheral Blood Stem Cell Transplantation in Adults with Myelodysplastic Syndrome after Reduced-Intensity Conditioning Regimen: A Collaborative Study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party
|
Robin, Marie |
|
2015 |
21 |
3 |
p. 489-495 7 p. |
artikel |
12 |
Decreased Nonrelapse Mortality after Unrelated Cord Blood Transplantation for Acute Myeloid Leukemia Using Reduced-Intensity Conditioning: A Prospective Phase II Multicenter Trial
|
Rio, Bernard |
|
2015 |
21 |
3 |
p. 445-453 9 p. |
artikel |
13 |
Editorial Board
|
|
|
2015 |
21 |
3 |
p. A2- 1 p. |
artikel |
14 |
Efficacy of Tacrolimus/Mycophenolate Mofetil as Acute Graft-Versus-Host Disease Prophylaxis and the Impact of Subtherapeutic Tacrolimus Levels in Children after Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation
|
Offer, Katharine |
|
2015 |
21 |
3 |
p. 496-502 7 p. |
artikel |
15 |
Fate of Patients with Newly Diagnosed Acute Myeloid Leukemia Who Fail Primary Induction Therapy
|
Othus, Megan |
|
2015 |
21 |
3 |
p. 559-564 6 p. |
artikel |
16 |
Hematopoietic Stem Cell Transplantation in Children with Refractory Cytopenia of Childhood: Single-Center Experience Using High-Dose Cytarabine Containing Myeloablative and Aplastic Anemia Oriented Reduced-Intensity Conditioning Regimens
|
Inagaki, Jiro |
|
2015 |
21 |
3 |
p. 565-569 5 p. |
artikel |
17 |
High Number of Memory T Cells Is Associated with Higher Risk of Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation
|
Loschi, Michael |
|
2015 |
21 |
3 |
p. 569-574 6 p. |
artikel |
18 |
Impact of Serotherapy on Immune Reconstitution and Survival Outcomes after Stem Cell Transplantations in Children: Thymoglobulin Versus Alemtuzumab
|
Storek, Jan |
|
2015 |
21 |
3 |
p. 385-386 2 p. |
artikel |
19 |
Impact of Serotherapy on Immune Reconstitution and Survival Outcomes After Stem Cell Transplantations in Children: Thymoglobulin Versus Alemtuzumab
|
Willemsen, Laura |
|
2015 |
21 |
3 |
p. 473-482 10 p. |
artikel |
20 |
Incidence Rate of Fluoroquinolone-Resistant Gram-Negative Rod Bacteremia among Allogeneic Hematopoietic Cell Transplantation Patients during an Era of Levofloxacin Prophylaxis
|
Miles-Jay, Arianna |
|
2015 |
21 |
3 |
p. 539-545 7 p. |
artikel |
21 |
Increased Bacterial Infections after Transfusion of Leukoreduced Non-Irradiated Blood Products in Recipients of Allogeneic Stem Cell Transplants after Reduced-Intensity Conditioning
|
Jaime-Pérez, José C. |
|
2015 |
21 |
3 |
p. 526-530 5 p. |
artikel |
22 |
Mammalian Target of Rapamycin Inhibitor–Associated Stomatitis in Hematopoietic Stem Cell Transplantation Patients Receiving Sirolimus Prophylaxis for Graft-versus-Host Disease
|
Villa, Alessandro |
|
2015 |
21 |
3 |
p. 503-508 6 p. |
artikel |
23 |
Masthead
|
|
|
2015 |
21 |
3 |
p. A1- 1 p. |
artikel |
24 |
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|
Jagasia, Madan H. |
|
2015 |
21 |
3 |
p. 389-401.e1 3622 p. |
artikel |
25 |
2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: Preface to the Series
|
Pavletic, Steven Z. |
|
2015 |
21 |
3 |
p. 387-388 2 p. |
artikel |
26 |
Officers, Directors, and Board Committee Chairs
|
|
|
2015 |
21 |
3 |
p. A3- 1 p. |
artikel |
27 |
Reconstitution of Natural Killer Cells in HLA-Matched HSCT after Reduced-Intensity Conditioning: Impact on Clinical Outcome
|
Pical-Izard, Caroline |
|
2015 |
21 |
3 |
p. 429-439 11 p. |
artikel |
28 |
Risk Factors for Readmission after Allogeneic Hematopoietic Stem Cell Transplantation and Impact on Overall Survival
|
Spring, Laura |
|
2015 |
21 |
3 |
p. 509-516 8 p. |
artikel |
29 |
Second Autologous Stem Cell Transplant: An Effective Therapy for Relapsed Multiple Myeloma
|
Singh Abbi, Kamal Kant |
|
2015 |
21 |
3 |
p. 468-472 5 p. |
artikel |
30 |
Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study
|
Bejanyan, Nelli |
|
2015 |
21 |
3 |
p. 454-459 6 p. |
artikel |
31 |
Table of Contents
|
|
|
2015 |
21 |
3 |
p. A8-A12 nvt p. |
artikel |
32 |
“Uncovering” the Recovery of Natural Killer Cells after Reduced-Intensity Conditioning Transplantation
|
Bachanova, Veronika |
|
2015 |
21 |
3 |
p. 383-384 2 p. |
artikel |
33 |
Will Post-Transplantation Cell Therapies for Pediatric Patients Become Standard of Care?
|
Lankester, Arjan C. |
|
2015 |
21 |
3 |
p. 402-411 10 p. |
artikel |
34 |
Wilms Tumor Gene 1 Expression as a Predictive Marker for Relapse and Survival after Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes
|
Yoon, Jae-Ho |
|
2015 |
21 |
3 |
p. 460-467 8 p. |
artikel |